RT Journal Article
T1 Blood Flow Restriction in Oncological Patients: Advantages and Safety Considerations.
A1 Vinolo-Gil, Maria Jesus
A1 García-Campanario, Ismael
A1 Estebanez-Pérez, María-José
A1 Pastora-Bernal, José Manuel
A1 Rodríguez-Huguet, Manuel
A1 Martín-Vega, Francisco-Javier
A1 García Campanario, 
K1 Circulación sanguínea - Alteraciones
K1 Cáncer - Tratamiento
AB Background: Cancer, being a highly widespread disease on a global scale, has promptedresearchers to explore innovative treatment approaches. In this regard, blood flow restriction hasemerged as a promising procedure utilized in diverse clinical populations with favorable resultsincluding improvements in muscle strength, cardiovascular function, and postoperative recovery.The aim of this systematic review was to assess the efficacy of blood flow restriction in cancersurvivors. Methods: An investigation was carried out using various databases until February 2023:PubMed, Scientific Electronic Library Online, Physiotherapy Evidence Database, Scopus, Web ofScience, Cochrane Plus, SPORTDiscus, Physiotherapy and Podiatry of the Complutense Universityof Madrid, ScienceDirect, ProQuest, Research Library, Cumulative Index of Nursing and AlliedLiterature Complete Journal Storage, and the gray literature. To assess the methodological qualityof the studies, the PEDro scale was utilized, and the Cochrane Collaboration tool was employed toevaluate the risk of bias. Results: Five articles found that blood flow restriction was beneficial inimproving several factors, including quality of life, physical function, strength, and lean mass, andin reducing postoperative complications and the length of hospital stay. Conclusion: Blood flowrestriction can be a viable and effective treatment option. It is important to note that the caution withwhich one should interpret these results is due to the restricted quantity of articles and significantvariation, and future research should concentrate on tailoring the application to individual patients,optimizing load progression, ensuring long-term follow-up, and enhancing the methodological rigorof studies, such as implementing sample blinding.
PB MDPI
YR 2023
FD 2023-07-19
LK https://hdl.handle.net/10630/32123
UL https://hdl.handle.net/10630/32123
LA eng
NO Vinolo-Gil, M. J., García-Campanario, I., Estebanez-Pérez, M., Pastora-Bernal, J., Rodríguez-Huguet, M., & Martín-Vega, F. J. (2023). Blood Flow Restriction in Oncological Patients: Advantages and Safety Considerations. Healthcare, 11(14), 2062. https://doi.org/10.3390/healthcare11142062
NO Partial funding for open access charge: Universidad de Málaga
DS RIUMA. Repositorio Institucional de la Universidad de Málaga
RD 3 mar 2026